ar.kravchenko
TL2 Moderator · Recife
Contributes reviews on supplier material. Based in Recife.
Joined 9 April 2025 · last posted 3d
80 posts, newest first. Showing up to 150.
-
Here for the analytics and not much else Replied, post #92 · Lounge › Introductions · 25 Jul 2026 · 28 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What a certificate commits its issuer to Replied, post #102 · Analytics › COA interpretation · 25 Jul 2026 · 0 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Restarting after a long gap: what the labelling implies Replied, post #42 · Practice › Dosing & titration · 24 Jul 2026 · 27 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Athletes in weight-category sports: a different risk calculus Replied, post #36 · Clinical › Special populations · 22 Jul 2026 · 1 like Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #55 · Sourcing › Regulatory · 22 Jul 2026 · 11 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Follow-up: Signs of dehydration worth acting on Replied, post #32 · Safety › Adverse events · 20 Jul 2026 · 13 likes post #31 is right about the mechanism and I think understates the practical bit. Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back…
-
Tracking intake honestly when appetite is absent Replied, post #97 · Nutrition & Training › Protein & intake · 13 Jul 2026 · 18 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #75 · Analytics › Home & field testing · 13 Jul 2026 · 14 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #87 · Analytics › Home & field testing · 9 Jul 2026 · 3 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #45 · Analytics › Impurities & related substances · 3 Jul 2026 · 4 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #50 · Clinical › Bloodwork · 29 Jun 2026 · 2 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
A site rotation scheme that is easy enough to actually follow Replied, post #78 · Practice › Administration · 2 Jun 2026 · 1 like post #77 is right about the mechanism and I think understates the practical bit. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is…
-
Request: a per-category review queue Replied, post #7 · Meta › Feature requests · 27 May 2026 · 9 likes I read post #5 twice before replying, because I had assumed the opposite. Alternatives: if you have thought of a way the current site might already serve your need,…
-
Injection volume, overload, and peak distortion Replied, post #22 · Analytics › HPLC & UHPLC · 26 May 2026 · 11 likes I read post #20 twice before replying, because I had assumed the opposite. Before anything else: what was the gradient, and at what wavelength? Area percent at…
-
About the COA interpretation category Replied, post #12 · Analytics › COA interpretation · 22 May 2026 · 0 likes post #11 is right about the mechanism and I think understates the practical bit. What fields matter on a certificate: lot number matching the vial, test date, the…
-
Reading a home test result without over-claiming Replied, post #50 · Analytics › Home & field testing · 21 May 2026 · 16 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #30 · Analytics › COA interpretation · 3 May 2026 · 25 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Journal club: is percentage weight change the right endpoint? Replied, post #58 · Evidence › Journal club · 11 Apr 2026 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Requesting a translation of an existing page — the long version Replied, post #3 · Documentation › Wiki requests · 5 Apr 2026 · 6 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Sample handling between despatch and injection Replied, post #15 · Analytics › Method validation · 3 Apr 2026 · 15 likes post #14 answers the question as asked. The question underneath it is different. Why two laboratories may disagree: after validating the same method, they may still…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #24 · Practice › Administration · 2 Apr 2026 · 21 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #5 · Devices › Syringes & needles · 31 Mar 2026 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Run-in periods and the population they select Replied, post #82 · Evidence › Trials · 15 Mar 2026 · 0 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #25 · Evidence › Trials · 9 Mar 2026 · 8 likes post #24 answers the question as asked. The question underneath it is different. Risk of bias: structured appraisal of internal validity. Key things to assess:…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #78 · Practice › Storage & stability · 9 Mar 2026 · 0 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Measurement error in a self-reported exposure Replied, post #84 · Evidence › Study critique · 26 Feb 2026 · 0 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
German, French and Dutch differences, compared Started this topic · Regional › European Union · 23 Feb 2026 · 0 likes German, French and Dutch differences, compared — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #66 · Evidence › Study critique · 19 Feb 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Heterogeneity as information rather than as a nuisance Replied, post #96 · Evidence › Meta-analyses · 9 Feb 2026 · 14 likes Picking up post #93: that is the part I would want checked first. Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #63 · Access › International · 19 Jan 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Specification in the result column: why that is a meaningful error Replied, post #103 · Analytics › COA interpretation · 10 Jan 2026 · 0 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #31 · Practice › Interactions · 6 Jan 2026 · 6 likes Worth separating two things that post #27 runs together. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining…
-
Preprint servers and what screening they do Replied, post #16 · Evidence › Preprints · 5 Jan 2026 · 21 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #66 · Practice › Side effects · 28 Dec 2025 · 7 likes I read post #64 twice before replying, because I had assumed the opposite. Vomiting: when it is expected (first-dose reactions or early titration) and when it is a…
-
Documentation that materially improves an appeal's chances Replied, post #92 · Access › Insurance & coverage · 6 Dec 2025 · 0 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #10 · Compounds › Tirzepatide · 22 Nov 2025 · 5 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #94 · Safety › Adverse events · 5 Nov 2025 · 5 likes Picking up post #91: that is the part I would want checked first. Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation)…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #71 · Safety › Adverse events · 30 Oct 2025 · 0 likes How to document: date, exact symptom or event, severity, duration, outcome, any medical attention sought. Detailed documentation is far more useful than a vague report.
-
A 40-week log with the measurement method stated Replied, post #64 · Outcomes › Progress reports · 24 Oct 2025 · 1 like Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #13 · Clinical › Special populations · 14 Oct 2025 · 1 like Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Research-use-only labelling: what it means and what it does not Replied, post #44 · Sourcing › Regulatory · 11 Oct 2025 · 0 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Second pass at: The mass-error checker and its intended scope Replied, post #32 · Data & Tools › Calculators · 6 Oct 2025 · 0 likes post #31 is right about the mechanism and I think understates the practical bit. Titration planning: a calculator that shows you the escalation schedule for different…
-
Freeze-thaw and why one cycle is not the same as five Replied, post #8 · Practice › Storage & stability · 5 Oct 2025 · 0 likes On post #4 — agreed on the reasoning, with one qualification. Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #66 · Practice › Administration · 17 Sep 2025 · 4 likes post #65 answers the question as asked. The question underneath it is different. Bleeding at the injection site: normal and usually minimal. A little blood at the…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #119 · Evidence › Study critique · 16 Sep 2025 · 1 like Coming back to post #117, because the follow-up matters more than the original answer. Building consensus on which criticisms matter: if everyone agrees that the sample…
-
Managing an unplanned gap in supply — what changed since Replied, post #52 · Access › Shortages · 2 Sep 2025 · 27 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #39 · Sourcing › Regulatory · 31 Aug 2025 · 30 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #35 · Sourcing › Vendor reports · 4 Aug 2025 · 4 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #4 · Start Here › How to Ask · 29 Jul 2025 · 10 likes the opening post answers the question as asked. The question underneath it is different. Avoid "any advice?" at the end. It is so generic that people do not know which…
-
The storage lookup and where its data comes from Replied, post #7 · marked as the solution · Data & Tools › Calculators · 25 Jul 2025 · 10 likes On post #3 — agreed on the reasoning, with one qualification. Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that…
-
Repeatability versus intermediate precision Replied, post #97 · Analytics › Method validation · 29 Jun 2025 · 14 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #155 · Compounds › Cagrilintide & amylin analogues · 20 Jun 2025 · 1 like Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #13 · Clinical › Special populations · 24 May 2025 · 0 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
-
Deamidation and the close-eluting pair it produces Replied, post #35 · Analytics › Impurities & related substances · 30 Apr 2025 · 0 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Hello from a laboratory that does not do peptides Started this topic · Lounge › Introductions · 17 Apr 2025 · 17 likes Hello from a laboratory that does not do peptides — setting out what I have, and where I think it stops being reliable. Lower-stakes topic, but the sourcing rule still…
-
Review cadence: how often is a page actually re-checked? Replied, post #23 · Documentation › Doc review · 17 Apr 2025 · 8 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
A report I filed that turned out to be wrong, and the correction Replied, post #3 · Sourcing › Vendor reports · 2 Apr 2025 · 7 likes Coming back to the opening post, because the follow-up matters more than the original answer. Date the report: when the analysis was done matters. Material can degrade…
-
Follow-up: Requesting a page: what makes a good request Replied, post #14 · Documentation › Wiki requests · 26 Mar 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What a 2 ppm match establishes, and what it does not Replied, post #5 · Analytics › Mass spectrometry · 12 Mar 2025 · 3 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #3 · Sourcing › Independent verification · 12 Mar 2025 · 0 likes Worth separating two things that the opening post runs together. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #58 · Sourcing › Red flags · 27 Feb 2025 · 7 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #116 · Compounds › Semaglutide · 26 Feb 2025 · 30 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #23 · Compounds › Tirzepatide · 17 Feb 2025 · 1 like Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
UK access routes, dated and sourced — a second dataset Replied, post #39 · Regional › UK & Ireland · 15 Feb 2025 · 12 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #40 · Evidence › Meta-analyses · 2 Feb 2025 · 0 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #9 · marked as the solution · Compounds › Repair & healing peptides · 26 Jan 2025 · 11 likes This follows post #6 rather than contradicting it. What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #4 · Practice › Reconstitution · 23 Jan 2025 · 28 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #33 · Compounds › Semaglutide · 20 Jan 2025 · 19 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 9 Jan 2025 · 27 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #19 · Practice › Reconstitution · 8 Jan 2025 · 32 likes post #18 answers the question as asked. The question underneath it is different. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #34 · Compounds › Oral incretins · 26 Dec 2024 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #100 · Compounds › Semaglutide · 25 Dec 2024 · 12 likes This follows post #97 rather than contradicting it. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #49 · Compounds › Tirzepatide · 22 Nov 2024 · 0 likes I read post #47 twice before replying, because I had assumed the opposite. Storage and stability: published data on licensed tirzepatide formulations exists and is…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #66 · Devices › Syringes & needles · 16 Nov 2024 · 25 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #27 · Evidence › Journal club · 8 Nov 2024 · 0 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
US compounding rules and how they changed Replied, post #56 · Regional › North America · 4 Nov 2024 · 28 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #22 · Clinical › Prescriber conversations · 18 Jul 2024 · 12 likes Coming back to post #20, because the follow-up matters more than the original answer. Clarifying indication: if a compound is approved for diabetes but you have obesity…
-
Journal club: FLOW and the renal composite, component by component Replied, post #76 · Evidence › Journal club · 16 Jul 2024 · 17 likes Picking up post #73: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Cold packs, phase-change material, and what survives ten days Replied, post #69 · Sourcing › Logistics · 4 Jul 2024 · 0 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Cold packs, phase-change material, and what survives ten days Replied, post #9 · Sourcing › Logistics · 12 Jun 2024 · 0 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…